🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
307,02 USD
Máx. histórico
322,75
3 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-4,87%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-4,87%
Cierre anterior
322,75
Rango de hoy
306,17 – 324,95
Volumen hoy
265.433
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 32,35 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/12/2025 | 189,91 | 193,54 | 188,17 | 189,07 | -0,59% | 2,83% | 88.300 |
| 30/12/2025 | 195,30 | 195,30 | 188,66 | 190,20 | -2,54% | 3,40% | 230.800 |
| 29/12/2025 | 196,00 | 196,04 | 193,65 | 195,16 | -0,34% | 1,22% | 97.100 |
| 26/12/2025 | 198,21 | 198,80 | 194,50 | 195,83 | -0,66% | 2,17% | 98.200 |
| 24/12/2025 | 196,75 | 197,62 | 194,44 | 197,14 | -0,13% | 1,62% | 74.500 |
| 23/12/2025 | 198,31 | 202,27 | 196,23 | 197,39 | -0,29% | 3,05% | 114.600 |
| 22/12/2025 | 200,89 | 202,97 | 197,33 | 197,96 | -1,18% | 2,81% | 142.800 |
| 19/12/2025 | 197,87 | 202,50 | 197,81 | 200,33 | +0,97% | 2,37% | 429.900 |
| 18/12/2025 | 195,03 | 200,00 | 194,00 | 198,41 | +1,96% | 3,08% | 305.900 |
| 17/12/2025 | 192,50 | 196,00 | 189,03 | 194,59 | +1,02% | 3,62% | 183.100 |
| 16/12/2025 | 191,68 | 196,00 | 188,69 | 192,63 | -0,13% | 3,81% | 261.500 |
| 15/12/2025 | 190,44 | 194,89 | 190,44 | 192,88 | +1,76% | 2,34% | 271.100 |
| 12/12/2025 | 183,30 | 190,28 | 181,68 | 189,55 | +3,51% | 4,69% | 284.900 |
| 11/12/2025 | 185,93 | 186,63 | 179,65 | 183,13 | -0,49% | 3,75% | 221.000 |
| 10/12/2025 | 187,77 | 188,54 | 183,44 | 184,03 | -0,97% | 2,72% | 236.600 |
| 09/12/2025 | 189,29 | 192,44 | 185,23 | 185,83 | +0,63% | 3,81% | 162.000 |
| 08/12/2025 | 186,70 | 189,76 | 183,23 | 184,67 | -0,11% | 3,50% | 203.900 |
| 05/12/2025 | 188,58 | 189,46 | 184,22 | 184,87 | -1,93% | 2,78% | 302.600 |
| 04/12/2025 | 192,75 | 194,90 | 187,87 | 188,50 | -2,35% | 3,65% | 194.300 |
| 03/12/2025 | 196,94 | 197,00 | 191,27 | 193,03 | -1,06% | 2,91% | 218.300 |
| 02/12/2025 | 196,97 | 201,49 | 194,21 | 195,10 | -0,95% | 3,70% | 227.100 |
| 01/12/2025 | 199,88 | 200,60 | 192,71 | 196,97 | -3,06% | 3,95% | 224.300 |
| 28/11/2025 | 206,18 | 206,67 | 200,74 | 203,18 | -1,45% | 2,88% | 121.900 |
| 26/11/2025 | 204,52 | 207,24 | 203,23 | 206,16 | +1,30% | 1,96% | 285.600 |
| 25/11/2025 | 207,75 | 209,10 | 202,53 | 203,52 | -1,63% | 3,16% | 212.000 |
| 24/11/2025 | 199,23 | 207,03 | 199,18 | 206,89 | +3,84% | 3,94% | 254.300 |
| 21/11/2025 | 199,49 | 204,27 | 198,90 | 199,23 | +0,10% | 2,69% | 264.600 |
| 20/11/2025 | 209,13 | 210,76 | 198,82 | 199,03 | -3,41% | 5,71% | 235.300 |
| 19/11/2025 | 207,05 | 208,05 | 203,47 | 206,05 | -0,48% | 2,21% | 243.400 |
| 18/11/2025 | 201,77 | 208,82 | 199,00 | 207,05 | +2,83% | 4,87% | 247.400 |